Abstract

Eruptive lichen planus (LP) is a rare variation of lichen planus that is usually widely distributed and disseminate rapidly. This variation is not well studied, and little is known about the etiologies. Though it is thought to be a result of an autoimmune reaction targeting the basal keratinocytes [1]. Treatments for eruptive LP commonly include oral corticosteroids, retinoids and immunosuppressants. But patients are always reluctant to choose these drugs due to the poor efficacy and more side-effects. Here, we report a case of eruptive LP successfully treated with tofacitinib.